In his CEO Commentary, Frederic Revah, Ph.D., underscores the dedication, expertise and successes of Genethon's 240 scientists and professional staff as they pursue new gene therapy treatments for ...
Discusses 3-Year Topline Results From EMBARK Phase 3 Trial of ELEVIDYS in Duchenne Muscular Dystrophy January 26, ...
The NPP government’s efforts to abolish MPs’ pensions have met with stiff resistance. All members of the current Parliament, including 159 NPP legislators, will lose their retirement benefits unless ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results